Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
December 20, 2024
Organigram Reports Fourth Quarter and Fiscal 2024 Results
December 18, 2024
Organigram Reports Fourth Quarter and Fiscal 2024 Results
December 11, 2024
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
December 6, 2024
Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share
November 26, 2024
Organigram Launches FAST™ Nanoemulsion Gummies
September 3, 2024
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
August 13, 2024
Organigram Reports Third Quarter Fiscal 2024 Results
August 7, 2024
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
August 6, 2024
Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
July 29, 2024
Organigram Announces Appointment of Craig Harris to Board of Directors
July 24, 2024
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
June 25, 2024
Organigram Invests in Sanity Group, a Leading German Cannabis Company
May 28, 2024
Organigram Signs Three Year Supply Agreement with Avida Medical in UK
May 14, 2024
Organigram Reports Second Quarter Fiscal 2024 Results
May 8, 2024
Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
April 8, 2024
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
April 3, 2024
Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
April 2, 2024
Organigram Successfully Closes Previously Announced Underwritten Public Offering
March 27, 2024
Organigram Announces Pricing of Overnight Marketed Public Offering
March 26, 2024
Organigram Announces Launch of Overnight Marketed Public Offering
March 26, 2024
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
March 22, 2024
Organigram Receives Health Canada’s Final Redetermination on Jolts
February 28, 2024
Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty
February 13, 2024
Organigram Reports First Quarter Fiscal 2024 Results
February 7, 2024
Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024
January 31, 2024
Organigram Completes First Shipment to Germany, Extending its International Reach
January 24, 2024
Organigram Announces the First Tranche Closing from BAT Investment
January 19, 2024
Organigram Announces Appointment of Karina Gehring to Board of Directors
January 18, 2024
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT